3-methylxanthine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1939-2018
051019392017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
RNAs often exhibit a high degree of conformational dynamics and heterogeneity, leading to a rugged energy landscape. However, the… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2000
2000
In a continuing effort to explore structural and functional dynamics in RNA catalysis, we have created a series of allosteric… (More)
Is this relevant?
1999
1999
1 To investigate the effect of moderate hypoxia alone or combined with an inflammatory reaction or after 3-methylcholanthrene… (More)
Is this relevant?
1996
1996
A strain of Serratia marcescens showing the ability to degrade caffeine and other methylxanthines was isolated from soil under… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1996
1996
In this paper we describe the kinetics of formation of 1-methylxanthine (1-MX), 3-methylxanthine (3-MX) and 1,3-dimethyluric acid… (More)
Is this relevant?
1985
1985
Rats were trained to discriminate methylxanthines from saline under a two-lever concurrent variable ratio schedule of… (More)
Is this relevant?
1984
1984
The effects of 3-methylxanthine, the pharmacologically active metabolite of theophylline, on the kidneys of Wistar rats after… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
1. The potencies of caffeine and related methylxanthines as adenosine antagonists were assessed with respect to three apparent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
1983
1983
3H-Flunitrazepam (500 pM) was used to estimate the inhibitory effects of caffeine, theophylline, theobromine and 3-methylxanthine… (More)
Is this relevant?
1979
1979
The metabolism and kinetics of 14C-labeled theophylline have been studied after intravenous doses of 100 mg to healthy subjects… (More)
Is this relevant?